In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

The MM+M editorial team was heartened by the progress made treating Alzheimer’s disease, the case of KJ Muldoon and ...

Calling for a revival of the concept of a co-operative commonwealth as a “solidarity stack” to reshape AI, he added: “Integrity can be world changing … we can show the co-operative principles by ...

Language is more strongly controlled by the left half of the brain, while other functions are more strongly controlled by the ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

A 1966 example of the Ford GT40 MkII is heading to auction in January—and it’s not just any example of the already ultra-rare car, but the “most original” one. Eleven MkII GT40s were built, and just ...

In a scene that perfectly captures the strangeness of American politics today, President Trump, a billionaire and self-styled champion of American business (at least the ones he likes) was all smiles ...